Marine biomedicine (China)
Pharmaceuticals, devices, cosmetics and new raw materials developed from marine biological resources, with Hainan using regulatory-sandbox measures for new marine materials — long, costly drug-development chain.
1 · What it gives
Marine biomedicine develops pharmaceuticals, medical devices, cosmetics and new raw materials from marine biological resources using modern science. The chain runs lead-compound discovery, drug-ability evaluation, systematic preclinical research and clinical trials. Support is provincial and municipal: the sources cite national, Hainan, Qingdao and Xiamen levels.
2 · What it replaces 6
3 · How to implement 3 steps
- 1Lead discoveryDiscover lead compounds.
- 2Drug-abilityEvaluate drug-ability.
- 3Preclinical and clinicalRun systematic preclinical research and clinical trials.
4 · Who delivers
Matched suppliers (matched automatically)
| LG Chem | South Korea | Producer | active |
| COFCO Biotechnology 中粮科技 (SZ 000930) | China | Research / RTO | active |
| EverEnviro Resource Management | India | Not classified | active |
| GEA Group | Germany | Distributor | active |
| Mitr Phol Group | Thailand | Research / RTO | active |
| Pacific Biochar | United States | Distributor | active |
| Taiwan Sugar Corporation (TSC) | Taiwan | Research / RTO | active |
| Kolon Industries | South Korea | Producer | active |
| Star Lake/Eppen 星湖科技 (SSE 600866) | China | Producer | active |
| SyncoZymes (Shanghai) | China | Producer | active |
| Sanergy | Kenya | Services / consulting | active |
| Thermax | India | Services / consulting | active |
Leading companies and institutes (from the brief)
Qingdao Mingyue Seaweed Group, Hainan Jiuzhitang Pharmaceutical and Force Pharmaceuticals (Xiamen) are named. Others are matched by the portal under Marine & Blue Bioeconomy and Pharma.
5 · Rules & route to market
none for the service; operator permits (integrated environmental permit ~1 month)
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
The sources reviewed on 2026-10-16 identified no the US regulator or standard specific to this technology. Treat the route as case-by-case and ask for a check.
European Union
The sources reviewed on 2026-10-16 identified no the EU regulator or standard specific to this technology. Treat the route as case-by-case and ask for a check.
China
The Hainan Provincial Medical Products Administration manages and supports the industry through specific measures, including regulatory-sandbox initiatives for new marine materials.
6 · Money: tenders & grants
| Grant | Circular innovative advanced materials: facilitating the transition from design to markets (RIA) (Innovative … European Commission · EU | Feb 2, 2027 109 days |
| Grant | Developing novel recycling technologies for complex plastic materials applying biotech solutions European Commission · EU | Sep 22, 2027 341 days |
| Grant | Advancing sustainable maintenance and repair measures for existing buildings European Commission · EU | Dec 1, 2026 46 days |
| Grant | Circularity of seafood supply chain European Commission · EU | Sep 21, 2027 340 days |
| Grant | Open topic: Using the Circular Cities and Regions Initiative to strengthen urban manufacturing in support of … European Commission · EU | Apr 8, 2027 174 days |
7 · Tech stack & innovations
Main risks from the sources: high technical difficulty in drug development, long research cycles, high cost and a shortage of professional talent.
Sources 4
- Amr.hainan.gov.cn — amr.hainan.gov.cn 2026-10-16
- Qdmbri.com — www.qdmbri.com 2026-10-16
- Tio.org.cn — www.tio.org.cn 2026-10-16
- Gd.xinhuanet.com — www.gd.xinhuanet.com 2026-10-16